(2026). The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio (NLR) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA–IIIB Non‐Small Cell Lung Cancer in Real‐World Practice. Thoracic Cancer.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio (NLR) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA–IIIB Non‐Small Cell Lung Cancer in Real‐World Practice."
Thoracic Cancer 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio (NLR) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA–IIIB Non‐Small Cell Lung Cancer in Real‐World Practice."
Thoracic Cancer, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.